centchroman has been researched along with Disease Models, Animal in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chauhan, N; Chauhan, SC; Hafeez, BB; Jaggi, M; Maher, DM; Mandil, H; Singh, MM; Yallapu, MM | 1 |
| Arshad, M; Ghosh, R; Sawlani, V; Sengupta, S; Sharma, S; Singh, MM | 1 |
2 other study(ies) available for centchroman and Disease Models, Animal
| Article | Year |
|---|---|
Ormeloxifene nanotherapy for cervical cancer treatment.
Topics: Animals; Benzopyrans; Carcinogenesis; Cell Line, Tumor; Cell Membrane; Cell Proliferation; Cell Survival; Clone Cells; Disease Models, Animal; Endocytosis; Erythrocytes; Female; Hemolysis; Humans; Materials Testing; Membrane Potential, Mitochondrial; Mice, Nude; Nanoparticles; Polylactic Acid-Polyglycolic Acid Copolymer; Serum; Uterine Cervical Neoplasms | 2019 |
In vitro anti-resorptive activity and prevention of ovariectomy-induced osteoporosis in female Sprague-Dawley rats by ormeloxifene, a selective estrogen receptor modulator.
Topics: Animals; Autopsy; Benzopyrans; Body Weight; Bone and Bones; Bone Density; Bone Resorption; Calcium; Centchroman; Chick Embryo; Densitometry; Disease Models, Animal; Epithelial Cells; Ethinyl Estradiol; Female; Femur; Osteocalcin; Osteoporosis; Ovary; Parathyroid Hormone; Piperidines; Rats; Rats, Sprague-Dawley; Selective Estrogen Receptor Modulators; Tamoxifen; Tibia | 2004 |